ERASCA INC's ticker is and the CUSIP is 29479A108. A total of 107 filers reported holding ERASCA INC in Q4 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $79,608 | -0.9% | 40,410 | +38.8% | 0.00% | – |
Q2 2023 | $80,333 | +113.7% | 29,106 | +124.5% | 0.00% | – |
Q1 2023 | $37,593 | -98.4% | 12,963 | -95.8% | 0.00% | -100.0% |
Q3 2022 | $2,391,000 | +41.4% | 306,540 | +1.0% | 0.00% | +100.0% |
Q2 2022 | $1,691,000 | -35.1% | 303,537 | +0.1% | 0.00% | -50.0% |
Q1 2022 | $2,607,000 | -44.8% | 303,174 | +0.0% | 0.00% | -33.3% |
Q4 2021 | $4,721,000 | -24.1% | 303,055 | +3.4% | 0.00% | -25.0% |
Q3 2021 | $6,221,000 | – | 293,136 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 11,055,554 | $21,779,441 | 14.15% |
EDBI Pte Ltd | 888,888 | $1,751,109 | 1.90% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,926,000 | $3,794,220 | 1.28% |
Cormorant Asset Management, LP | 10,813,246 | $21,302,095 | 1.24% |
AH Equity Partners LSV II, L.L.C. | 312,500 | $615,625 | 0.64% |
Artal Group S.A. | 4,721,194 | $9,301 | 0.40% |
PFM Health Sciences, LP | 3,930,633 | $7,743,347 | 0.36% |
ARMISTICE CAPITAL, LLC | 8,356,000 | $16,461,320 | 0.25% |
SANDERS MORRIS HARRIS LLC | 425,297 | $816,569 | 0.17% |
Prosight Management, LP | 264,710 | $521,479 | 0.16% |